Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: Combination of parameters does not improve diagnostic accuracy of calprotectin

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 7, 2007, Pages 1035-1042

  Schroder O ^a   Naumann, M ^a   Shastri, Y ^a   Povse, N ^a   Stein, J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALPROTECTIN; ELASTASE; LACTOFERRIN;

ADULT; AGED; ARTICLE; CHRONIC DIARRHEA; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIGESTIVE TRACT PARAMETERS; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; SCREENING TEST;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; FECES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 34548661281     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03457.x     Document Type: Article

References (28)

1. Delvaux M. Functional bowel disorders and irritable bowel syndrome in Europe. Aliment Pharmacol Ther 2003 18 (Suppl. 3 75 9.
2. Desai D, Faubion WA, Sandborn WJ. Review article: Biological activity markers in inflammatory bowel disease. Aliment Pharmacol Ther 2007 25 : 247 55.
3. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995 80 : 256 67.
4. Akin DT, Lu MQ, Lu SJ, Kendall S, Rundegren J, Arnold RR. Bactericidal activity of different forms of lactoferrin. Adv Exp Med Biol 1994 357 : 61 70.
5. Guerrant RL, Araujo V, Soares E, et al. Measurement of fecal lactoferrin as a marker of fecal leukocytes. J Clin Microbiol 1992 30 : 1238 42.
6. Andersson KB, Sletten K, Berntzen HB, et al. The leucocyte L1 protein: identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components. Scand J Immunol 1988 28 : 241 5.
7. Bjerke K, Halstensen TS, Jahnsen F, Pulford K, Brandtzaeg P. Distribution of macrophages and granulocytes expressing L1 protein (calprotectin) in human Peyer's patches compared with normal ileal lamina propria and mesenteric lymph nodes. Gut 1993 34 : 1357 63.
8. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999 34 : 50 4.
9. Klass HJ, Neale G. Serum and faecal lysozyme in inflammatory bowel disease. Gut 1978 19 : 233 9.
10. Dwarakanath AD, Finnie IA, Beesley CM, et al. Differential excretion of leucocyte granule components in inflammatory bowel disease: implications for pathogenesis. Clin Sci (Lond) 1997 92 : 307 13.
11. Adeyemi EO, Hodgson HJ. Faecal elastase reflects disease activity in active ulcerative colitis. Scand J Gastroenterol 1992 27 : 139 42.
12. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992 339 : 89 91.
13. De Jong NSH, Leach ST, Day AS. Fecal S100A12: a novel non-invasive marker in children with Crohn's disease. Inflamm Bowel Dis 2006 12 : 566 72.
14. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999 45 (Suppl. 2 II43 7.
15. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976 70 : 439 44.
16. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989 298 : 82 6.
17. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000 6 : 8 15.
18. Silberer H, Kuppers B, Mickisch O, et al. H. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Clin Lab 2005 51 : 117 26.
19. Langhorst J, Elsenbruch S, Mueller T, et al. Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm Bowel Dis 2005 11 : 1085 91.
20. von Roon AC, Karamountzos L, Purkayastha S, et al. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol 2007 102 : 803 13.
21. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002 123 : 450 60.
22. Kane SV, Sandborn WJ, Rufo PA, et al. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003 98 : 1309 14.
23. Fine KD, Ogunji F, George J, Niehaus MD, Guerrant RL. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea. Am J Gastroenterol 1998 93 : 1300 5.
24. Sugi KSO, Hiarata I, Katsu K. Faecal lactoferrin as a marker of disease activity in inflammatory bowel disease: comparison with other neutrophil derived proteins. Am J Gastroenterol 1996 91 : 927 34.
25. Bunn SK, Bisset WM, Main MJ, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001 32 : 171 7.
26. Roseth AG, Aadland E, Jahnsen J, Raknerud N. Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997 58 : 176 80.
27. Limburg PJ, Ahlquist DA, Sandborn WJ, et al. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy. Am J Gastroenterol 2000 95 : 2831 7.
28. Walker TR, Land ML, Kartashov A, et al. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007 44 : 414 22.